The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Meningococcal Vaccination Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2028
Synopsis
The Meningococcal Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Meningococcal Vaccination market size is estimated to be worth US$ 269.6 million in 2021 and is forecast to a readjusted size of USD 357.7 million by 2028 with a CAGR of 4.1% during review period. Pneumonia accounting for % of the Meningococcal Vaccination global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Polysaccharide segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Meningococcal Vaccination include GlaxoSmithKline, JN-International Medical, Novartis International, Sanofi, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Meningococcal Vaccination market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polysaccharide
Conjugate
Combination
Market segment by Application can be divided into
Pneumonia
Meningitis
Bacteremia
Others
The key market players for global Meningococcal Vaccination market are listed below:
GlaxoSmithKline
JN-International Medical
Novartis International
Sanofi
Pfizer
Baxter International
Biomed
Serum Institute of India
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meningococcal Vaccination product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Meningococcal Vaccination, with price, sales, revenue and global market share of Meningococcal Vaccination from 2019 to 2022.
Chapter 3, the Meningococcal Vaccination competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Vaccination breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Meningococcal Vaccination market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Meningococcal Vaccination.
Chapter 13, 14, and 15, to describe Meningococcal Vaccination sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
The Meningococcal Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Meningococcal Vaccination market size is estimated to be worth US$ 269.6 million in 2021 and is forecast to a readjusted size of USD 357.7 million by 2028 with a CAGR of 4.1% during review period. Pneumonia accounting for % of the Meningococcal Vaccination global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Polysaccharide segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Meningococcal Vaccination include GlaxoSmithKline, JN-International Medical, Novartis International, Sanofi, and Pfizer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Meningococcal Vaccination market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Polysaccharide
Conjugate
Combination
Market segment by Application can be divided into
Pneumonia
Meningitis
Bacteremia
Others
The key market players for global Meningococcal Vaccination market are listed below:
GlaxoSmithKline
JN-International Medical
Novartis International
Sanofi
Pfizer
Baxter International
Biomed
Serum Institute of India
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Meningococcal Vaccination product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Meningococcal Vaccination, with price, sales, revenue and global market share of Meningococcal Vaccination from 2019 to 2022.
Chapter 3, the Meningococcal Vaccination competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Meningococcal Vaccination breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Meningococcal Vaccination market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Meningococcal Vaccination.
Chapter 13, 14, and 15, to describe Meningococcal Vaccination sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Meningococcal Vaccination Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Meningococcal Vaccination Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Polysaccharide
1.2.3 Conjugate
1.2.4 Combination
1.3 Market Analysis by Application
1.3.1 Overview: Global Meningococcal Vaccination Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Bacteremia
1.3.5 Others
1.4 Global Meningococcal Vaccination Market Size & Forecast
1.4.1 Global Meningococcal Vaccination Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Meningococcal Vaccination Sales in Volume (2017-2028)
1.4.3 Global Meningococcal Vaccination Price (2017-2028)
1.5 Global Meningococcal Vaccination Production Capacity Analysis
1.5.1 Global Meningococcal Vaccination Total Production Capacity (2017-2028)
1.5.2 Global Meningococcal Vaccination Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Meningococcal Vaccination Market Drivers
1.6.2 Meningococcal Vaccination Market Restraints
1.6.3 Meningococcal Vaccination Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Meningococcal Vaccination Product and Services
2.1.4 GlaxoSmithKline Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 JN-International Medical
2.2.1 JN-International Medical Details
2.2.2 JN-International Medical Major Business
2.2.3 JN-International Medical Meningococcal Vaccination Product and Services
2.2.4 JN-International Medical Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Novartis International
2.3.1 Novartis International Details
2.3.2 Novartis International Major Business
2.3.3 Novartis International Meningococcal Vaccination Product and Services
2.3.4 Novartis International Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Sanofi
2.4.1 Sanofi Details
2.4.2 Sanofi Major Business
2.4.3 Sanofi Meningococcal Vaccination Product and Services
2.4.4 Sanofi Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Pfizer
2.5.1 Pfizer Details
2.5.2 Pfizer Major Business
2.5.3 Pfizer Meningococcal Vaccination Product and Services
2.5.4 Pfizer Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Baxter International
2.6.1 Baxter International Details
2.6.2 Baxter International Major Business
2.6.3 Baxter International Meningococcal Vaccination Product and Services
2.6.4 Baxter International Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Biomed
2.7.1 Biomed Details
2.7.2 Biomed Major Business
2.7.3 Biomed Meningococcal Vaccination Product and Services
2.7.4 Biomed Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Serum Institute of India
2.8.1 Serum Institute of India Details
2.8.2 Serum Institute of India Major Business
2.8.3 Serum Institute of India Meningococcal Vaccination Product and Services
2.8.4 Serum Institute of India Meningococcal Vaccination Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Meningococcal Vaccination Breakdown Data by Manufacturer
3.1 Global Meningococcal Vaccination Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Meningococcal Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Meningococcal Vaccination
3.4 Market Concentration Rate
3.4.1 Top 3 Meningococcal Vaccination Manufacturer Market Share in 2021
3.4.2 Top 6 Meningococcal Vaccination Manufacturer Market Share in 2021
3.5 Global Meningococcal Vaccination Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Meningococcal Vaccination Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Meningococcal Vaccination Market Size by Region
4.1.1 Global Meningococcal Vaccination Sales in Volume by Region (2017-2028)
4.1.2 Global Meningococcal Vaccination Revenue by Region (2017-2028)
4.2 North America Meningococcal Vaccination Revenue (2017-2028)
4.3 Europe Meningococcal Vaccination Revenue (2017-2028)
4.4 Asia-Pacific Meningococcal Vaccination Revenue (2017-2028)
4.5 South America Meningococcal Vaccination Revenue (2017-2028)
4.6 Middle East and Africa Meningococcal Vaccination Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Meningococcal Vaccination Sales in Volume by Type (2017-2028)
5.2 Global Meningococcal Vaccination Revenue by Type (2017-2028)
5.3 Global Meningococcal Vaccination Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Meningococcal Vaccination Sales in Volume by Application (2017-2028)
6.2 Global Meningococcal Vaccination Revenue by Application (2017-2028)
6.3 Global Meningococcal Vaccination Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Meningococcal Vaccination Sales by Type (2017-2028)
7.2 North America Meningococcal Vaccination Sales by Application (2017-2028)
7.3 North America Meningococcal Vaccination Market Size by Country
7.3.1 North America Meningococcal Vaccination Sales in Volume by Country (2017-2028)
7.3.2 North America Meningococcal Vaccination Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Meningococcal Vaccination Sales by Type (2017-2028)
8.2 Europe Meningococcal Vaccination Sales by Application (2017-2028)
8.3 Europe Meningococcal Vaccination Market Size by Country
8.3.1 Europe Meningococcal Vaccination Sales in Volume by Country (2017-2028)
8.3.2 Europe Meningococcal Vaccination Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Meningococcal Vaccination Sales by Type (2017-2028)
9.2 Asia-Pacific Meningococcal Vaccination Sales by Application (2017-2028)
9.3 Asia-Pacific Meningococcal Vaccination Market Size by Region
9.3.1 Asia-Pacific Meningococcal Vaccination Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Meningococcal Vaccination Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Meningococcal Vaccination Sales by Type (2017-2028)
10.2 South America Meningococcal Vaccination Sales by Application (2017-2028)
10.3 South America Meningococcal Vaccination Market Size by Country
10.3.1 South America Meningococcal Vaccination Sales in Volume by Country (2017-2028)
10.3.2 South America Meningococcal Vaccination Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Meningococcal Vaccination Sales by Type (2017-2028)
11.2 Middle East & Africa Meningococcal Vaccination Sales by Application (2017-2028)
11.3 Middle East & Africa Meningococcal Vaccination Market Size by Country
11.3.1 Middle East & Africa Meningococcal Vaccination Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Meningococcal Vaccination Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Meningococcal Vaccination and Key Manufacturers
12.2 Manufacturing Costs Percentage of Meningococcal Vaccination
12.3 Meningococcal Vaccination Production Process
12.4 Meningococcal Vaccination Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Meningococcal Vaccination Typical Distributors
13.3 Meningococcal Vaccination Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of TablesList of Tables
Table 1. Global Meningococcal Vaccination Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Meningococcal Vaccination Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Meningococcal Vaccination Product and Services
Table 6. GlaxoSmithKline Meningococcal Vaccination Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. JN-International Medical Basic Information, Manufacturing Base and Competitors
Table 8. JN-International Medical Major Business
Table 9. JN-International Medical Meningococcal Vaccination Product and Services
Table 10. JN-International Medical Meningococcal Vaccination Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Novartis International Basic Information, Manufacturing Base and Competitors
Table 12. Novartis International Major Business
Table 13. Novartis International Meningococcal Vaccination Product and Services
Table 14. Novartis International Meningococcal Vaccination Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Sanofi Basic Information, Manufacturing Base and Competitors
Table 16. Sanofi Major Business
Table 17. Sanofi Meningococcal Vaccination Product and Services
Table 18. Sanofi Meningococcal Vaccination Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Pfizer Basic Information, Manufacturing Base and Competitors
Table 20. Pfizer Major Business
Table 21. Pfizer Meningococcal Vaccination Product and Services
Table 22. Pfizer Meningococcal Vaccination Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Baxter International Basic Information, Manufacturing Base and Competitors
Table 24. Baxter International Major Business
Table 25. Baxter International Meningococcal Vaccination Product and Services
Table 26. Baxter International Meningococcal Vaccination Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Biomed Basic Information, Manufacturing Base and Competitors
Table 28. Biomed Major Business
Table 29. Biomed Meningococcal Vaccination Product and Services
Table 30. Biomed Meningococcal Vaccination Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Serum Institute of India Basic Information, Manufacturing Base and Competitors
Table 32. Serum Institute of India Major Business
Table 33. Serum Institute of India Meningococcal Vaccination Product and Services
Table 34. Serum Institute of India Meningococcal Vaccination Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Global Meningococcal Vaccination Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 36. Global Meningococcal Vaccination Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 37. Market Position of Manufacturers in Meningococcal Vaccination, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 38. Global Meningococcal Vaccination Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Meningococcal Vaccination Production Site of Key Manufacturer
Table 40. Meningococcal Vaccination New Entrant and Capacity Expansion Plans
Table 41. Meningococcal Vaccination Mergers & Acquisitions in the Past Five Years
Table 42. Global Meningococcal Vaccination Sales by Region (2017-2022) & (K Units)
Table 43. Global Meningococcal Vaccination Sales by Region (2023-2028) & (K Units)
Table 44. Global Meningococcal Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 45. Global Meningococcal Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 46. Global Meningococcal Vaccination Sales by Type (2017-2022) & (K Units)
Table 47. Global Meningococcal Vaccination Sales by Type (2023-2028) & (K Units)
Table 48. Global Meningococcal Vaccination Revenue by Type (2017-2022) & (USD Million)
Table 49. Global Meningococcal Vaccination Revenue by Type (2023-2028) & (USD Million)
Table 50. Global Meningococcal Vaccination Price by Type (2017-2022) & (US$/Unit)
Table 51. Global Meningococcal Vaccination Price by Type (2023-2028) & (US$/Unit)
Table 52. Global Meningococcal Vaccination Sales by Application (2017-2022) & (K Units)
Table 53. Global Meningococcal Vaccination Sales by Application (2023-2028) & (K Units)
Table 54. Global Meningococcal Vaccination Revenue by Application (2017-2022) & (USD Million)
Table 55. Global Meningococcal Vaccination Revenue by Application (2023-2028) & (USD Million)
Table 56. Global Meningococcal Vaccination Price by Application (2017-2022) & (US$/Unit)
Table 57. Global Meningococcal Vaccination Price by Application (2023-2028) & (US$/Unit)
Table 58. North America Meningococcal Vaccination Sales by Country (2017-2022) & (K Units)
Table 59. North America Meningococcal Vaccination Sales by Country (2023-2028) & (K Units)
Table 60. North America Meningococcal Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 61. North America Meningococcal Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 62. North America Meningococcal Vaccination Sales by Type (2017-2022) & (K Units)
Table 63. North America Meningococcal Vaccination Sales by Type (2023-2028) & (K Units)
Table 64. North America Meningococcal Vaccination Sales by Application (2017-2022) & (K Units)
Table 65. North America Meningococcal Vaccination Sales by Application (2023-2028) & (K Units)
Table 66. Europe Meningococcal Vaccination Sales by Country (2017-2022) & (K Units)
Table 67. Europe Meningococcal Vaccination Sales by Country (2023-2028) & (K Units)
Table 68. Europe Meningococcal Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 69. Europe Meningococcal Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 70. Europe Meningococcal Vaccination Sales by Type (2017-2022) & (K Units)
Table 71. Europe Meningococcal Vaccination Sales by Type (2023-2028) & (K Units)
Table 72. Europe Meningococcal Vaccination Sales by Application (2017-2022) & (K Units)
Table 73. Europe Meningococcal Vaccination Sales by Application (2023-2028) & (K Units)
Table 74. Asia-Pacific Meningococcal Vaccination Sales by Region (2017-2022) & (K Units)
Table 75. Asia-Pacific Meningococcal Vaccination Sales by Region (2023-2028) & (K Units)
Table 76. Asia-Pacific Meningococcal Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 77. Asia-Pacific Meningococcal Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 78. Asia-Pacific Meningococcal Vaccination Sales by Type (2017-2022) & (K Units)
Table 79. Asia-Pacific Meningococcal Vaccination Sales by Type (2023-2028) & (K Units)
Table 80. Asia-Pacific Meningococcal Vaccination Sales by Application (2017-2022) & (K Units)
Table 81. Asia-Pacific Meningococcal Vaccination Sales by Application (2023-2028) & (K Units)
Table 82. South America Meningococcal Vaccination Sales by Country (2017-2022) & (K Units)
Table 83. South America Meningococcal Vaccination Sales by Country (2023-2028) & (K Units)
Table 84. South America Meningococcal Vaccination Revenue by Country (2017-2022) & (USD Million)
Table 85. South America Meningococcal Vaccination Revenue by Country (2023-2028) & (USD Million)
Table 86. South America Meningococcal Vaccination Sales by Type (2017-2022) & (K Units)
Table 87. South America Meningococcal Vaccination Sales by Type (2023-2028) & (K Units)
Table 88. South America Meningococcal Vaccination Sales by Application (2017-2022) & (K Units)
Table 89. South America Meningococcal Vaccination Sales by Application (2023-2028) & (K Units)
Table 90. Middle East & Africa Meningococcal Vaccination Sales by Region (2017-2022) & (K Units)
Table 91. Middle East & Africa Meningococcal Vaccination Sales by Region (2023-2028) & (K Units)
Table 92. Middle East & Africa Meningococcal Vaccination Revenue by Region (2017-2022) & (USD Million)
Table 93. Middle East & Africa Meningococcal Vaccination Revenue by Region (2023-2028) & (USD Million)
Table 94. Middle East & Africa Meningococcal Vaccination Sales by Type (2017-2022) & (K Units)
Table 95. Middle East & Africa Meningococcal Vaccination Sales by Type (2023-2028) & (K Units)
Table 96. Middle East & Africa Meningococcal Vaccination Sales by Application (2017-2022) & (K Units)
Table 97. Middle East & Africa Meningococcal Vaccination Sales by Application (2023-2028) & (K Units)
Table 98. Meningococcal Vaccination Raw Material
Table 99. Key Manufacturers of Meningococcal Vaccination Raw Materials
Table 100. Direct Channel Pros & Cons
Table 101. Indirect Channel Pros & Cons
Table 102. Meningococcal Vaccination Typical Distributors
Table 103. Meningococcal Vaccination Typical Customers
List of Figures
Figure 1. Meningococcal Vaccination Picture
Figure 2. Global Meningococcal Vaccination Revenue Market Share by Type in 2021
Figure 3. Polysaccharide
Figure 4. Conjugate
Figure 5. Combination
Figure 6. Global Meningococcal Vaccination Revenue Market Share by Application in 2021
Figure 7. Pneumonia
Figure 8. Meningitis
Figure 9. Bacteremia
Figure 10. Others
Figure 11. Global Meningococcal Vaccination Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 12. Global Meningococcal Vaccination Revenue and Forecast (2017-2028) & (USD Million)
Figure 13. Global Meningococcal Vaccination Sales (2017-2028) & (K Units)
Figure 14. Global Meningococcal Vaccination Price (2017-2028) & (US$/Unit)
Figure 15. Global Meningococcal Vaccination Production Capacity (2017-2028) & (K Units)
Figure 16. Global Meningococcal Vaccination Production Capacity by Geographic Region: 2022 VS 2028
Figure 17. Meningococcal Vaccination Market Drivers
Figure 18. Meningococcal Vaccination Market Restraints
Figure 19. Meningococcal Vaccination Market Trends
Figure 20. Global Meningococcal Vaccination Sales Market Share by Manufacturer in 2021
Figure 21. Global Meningococcal Vaccination Revenue Market Share by Manufacturer in 2021
Figure 22. Meningococcal Vaccination Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 23. Top 3 Meningococcal Vaccination Manufacturer (Revenue) Market Share in 2021
Figure 24. Top 6 Meningococcal Vaccination Manufacturer (Revenue) Market Share in 2021
Figure 25. Global Meningococcal Vaccination Sales Market Share by Region (2017-2028)
Figure 26. Global Meningococcal Vaccination Revenue Market Share by Region (2017-2028)
Figure 27. North America Meningococcal Vaccination Revenue (2017-2028) & (USD Million)
Figure 28. Europe Meningococcal Vaccination Revenue (2017-2028) & (USD Million)
Figure 29. Asia-Pacific Meningococcal Vaccination Revenue (2017-2028) & (USD Million)
Figure 30. South America Meningococcal Vaccination Revenue (2017-2028) & (USD Million)
Figure 31. Middle East & Africa Meningococcal Vaccination Revenue (2017-2028) & (USD Million)
Figure 32. Global Meningococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 33. Global Meningococcal Vaccination Revenue Market Share by Type (2017-2028)
Figure 34. Global Meningococcal Vaccination Price by Type (2017-2028) & (US$/Unit)
Figure 35. Global Meningococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 36. Global Meningococcal Vaccination Revenue Market Share by Application (2017-2028)
Figure 37. Global Meningococcal Vaccination Price by Application (2017-2028) & (US$/Unit)
Figure 38. North America Meningococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 39. North America Meningococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 40. North America Meningococcal Vaccination Sales Market Share by Country (2017-2028)
Figure 41. North America Meningococcal Vaccination Revenue Market Share by Country (2017-2028)
Figure 42. United States Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Canada Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Mexico Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Europe Meningococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 46. Europe Meningococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 47. Europe Meningococcal Vaccination Sales Market Share by Country (2017-2028)
Figure 48. Europe Meningococcal Vaccination Revenue Market Share by Country (2017-2028)
Figure 49. Germany Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. France Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. United Kingdom Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Russia Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Italy Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Asia-Pacific Meningococcal Vaccination Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Meningococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 56. Asia-Pacific Meningococcal Vaccination Sales Market Share by Region (2017-2028)
Figure 57. Asia-Pacific Meningococcal Vaccination Revenue Market Share by Region (2017-2028)
Figure 58. China Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Japan Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Korea Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. India Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Southeast Asia Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Australia Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. South America Meningococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 65. South America Meningococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 66. South America Meningococcal Vaccination Sales Market Share by Country (2017-2028)
Figure 67. South America Meningococcal Vaccination Revenue Market Share by Country (2017-2028)
Figure 68. Brazil Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Argentina Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Middle East & Africa Meningococcal Vaccination Sales Market Share by Type (2017-2028)
Figure 71. Middle East & Africa Meningococcal Vaccination Sales Market Share by Application (2017-2028)
Figure 72. Middle East & Africa Meningococcal Vaccination Sales Market Share by Region (2017-2028)
Figure 73. Middle East & Africa Meningococcal Vaccination Revenue Market Share by Region (2017-2028)
Figure 74. Turkey Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Egypt Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Saudi Arabia Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. South Africa Meningococcal Vaccination Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Manufacturing Cost Structure Analysis of Meningococcal Vaccination in 2021
Figure 79. Manufacturing Process Analysis of Meningococcal Vaccination
Figure 80. Meningococcal Vaccination Industrial Chain
Figure 81. Sales Channel: Direct Channel vs Indirect Channel
Figure 82. Methodology
Figure 83. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
